Patients due to start chemotherapy/radio chemotherapy who meet the criteria of the cohorts listed below :
1. Squamous cell carcinoma of the upper aerodigestive tract (Non-metastatic, locally advanced, operable or not; Patients receiving concomitant radiochemotherapy using a platinum salt (cisplatin, carboplatin))
2. Cervical and endometrial cancer (ocally advanced, Non-metastatic; Patients receiving concomitant radiochemotherapy using a platinum salt (cisplatin, carboplatin))
3. Gynecological cancer (advanced stage ; Patient to receive platinum salt + paclitaxel chemotherapy)
4. Mammary carcinoma (localised; Patient to receive adjuvant or neoadjuvant chemotherapy with epirubicin and cyclophosphamide without other associated treatment (targeted therapy / immunotherapy))
5. Urothelial carcinoma (all stage ; Patient to receive neoadjuvant or adjuvant chemotherapy with platinum salt and gemcitabine)
6. Pancreatic adenocarcinoma (localised or metastatic ; Patients to be treated with gemcitamine alone or in combination with nab-paclitaxel)
OMS ≤ 2
Affiliation with a French social security scheme or beneficiary of such a scheme.
Signed informed consent indicating that the patient has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the study requirements and restrictions
You may not be if
Patients unable to collect / send stools for medical, geographical, social or psychological reasons.
Patients who have already received chemotherapy/radiochemotherapy.
Use of anti-infectives for systemic use within 6 months prior to the first sampling, or any other concomitant disease/condition that may influence stool analysis.
Pregnant women and nursing mothers.
Persons deprived of their liberty by judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a health or social institution for purposes other than research.
Adults subject to a legal protection measure - safeguard of justice, guardianship or curatorship - or unable to express their consent.
Clareo Health | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs
